Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for postoperative pain and depression in women undergoing second cesarean section
ChiCTR2300070341Phase 4Completed
- Sponsor
- Lishui People's Hospital
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postoperative pain, Afterpains and postpartum depression (PPD) (3 arms), sponsored by Lishui People's Hospital. Primary endpoints: Uterine Contraction Pain Score (VAS-U), Incision Resting Pain Score (VAS-R) and 1 more. Started Apr 2023; status: completed.
02
Drugs
esketamine
03
Conditions
postoperative painAfterpainspostpartum depression (PPD)
Beyond the preview
Go deeper on ChiCTR2300070341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070341.